Bill Snyder

(iStock image)
November 25, 2024

Potential treatment eyed for abnormal blood cell disorder

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminate potential,” or CHIP. 

By Bill Snyder
November 19, 2024

Eleven Vanderbilt scientists among world’s ‘highly cited’ researchers

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

By Bill Snyder
From left, Bradley Malin, PhD, Microsoft chief scientific officer Eric Horvitz, MD, PhD, and Peter Embí, MD, MS, addressed last week’s ADVANCE symposium on health care AI. (photo by Donn Jones)
November 12, 2024

Patient voices critical to success of artificial intelligence in health care

Sponsored by the Department of Biomedical Informatics, the symposium showcased the work of the department’s center for AI Discovery and Vigilance to Accelerate Innovation and Clinical Excellence.

By Bill Snyder
November 4, 2024

James Crowe Jr. honored for his innovative research on human antibodies

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.

By Bill Snyder
Eric Horvitz, MD, PhD
October 28, 2024

Microsoft’s Eric Horvitz set for next Discovery Lecture

Horvitz, an elected member of the National Academy of Engineering, is a pioneer in the applications of machine learning, AI and decision science.

By Bill Snyder
(iStock)
October 28, 2024

VUMC discovery aids effort to stop a deadly virus in Rwanda

A close cousin of Ebola, the Marburg virus is transmitted by fruit bats and by exposure to body fluids from infected individuals. There currently are no approved treatments or vaccines for MVD, which has a roughly 50% fatality rate.

By Bill Snyder
October 25, 2024

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.
By Bill Snyder
October 25, 2024

Asthma drug does not speed COVID-19 recovery: study

The study, a randomized and controlled clinical trial, tested the effectiveness of montelukast in 1,250 outpatients with acute post-COVID-19 symptoms.
By Bill Snyder and Shantell Kirkendoll
October 21, 2024

Clue to salt-sensitive blood pressure found

Despite the well-established link between high salt intake and cardiovascular disease and stroke, the mechanism of SSBP is poorly understood, and it remains an untreatable cardiovascular risk with no widely available diagnostic tool.
By Bill Snyder
October 15, 2024

MEGAMicrobe event for children set for Saturday, Oct. 26

The seventh annual event invites students to conduct science experiments, join in hands-on activities, and win prizes and giveaways.
By Bill Snyder
October 3, 2024

VUMC hosts symposium for aspiring physician-scientists

The event brings physician-scientists, resident physicians, MD, MD/PhD and undergraduate students together to promote mentorship, provide information and showcase student research.
By Bill Snyder
September 30, 2024

Ramakrishnan’s Discovery Lecture

Nobel laureate Venki Ramakrishnan, PhD, center, author of Why We Die: The New Science of Aging and the Quest for Immortality, delivered the Sept. 26 Discovery Lecture.
By Bill Snyder